207 related articles for article (PubMed ID: 8571194)
1. Effects of differing rates of protamine reversal of heparin anticoagulation.
Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
[TBL] [Abstract][Full Text] [Related]
2. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.
Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Tejwani S; Hulin MS; Stanley JC
J Surg Res; 1996 Jun; 63(1):280-6. PubMed ID: 8661211
[TBL] [Abstract][Full Text] [Related]
3. Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation.
Wakefield TW; Ucros I; Kresowik TF; Hinshaw DB; Stanley JC
J Vasc Surg; 1989 Jun; 9(6):772-7. PubMed ID: 2724464
[TBL] [Abstract][Full Text] [Related]
4. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
[TBL] [Abstract][Full Text] [Related]
5. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
Stefaniszyn HJ; Novick RJ; Salerno TA
J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
[TBL] [Abstract][Full Text] [Related]
6. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparin-protamine interaction. A prospective randomized study in human beings undergoing aortic reconstructive surgery.
Wakefield TW; Hantler CB; Lindblad B; Whitehouse WM; Stanley JC
J Vasc Surg; 1986 Jun; 3(6):885-9. PubMed ID: 3712636
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects.
Kanbak M; Kahraman S; Celebioglu B; Akpolat N; Ercan S; Erdem K
Anaesth Intensive Care; 1996 Oct; 24(5):559-63. PubMed ID: 8909666
[TBL] [Abstract][Full Text] [Related]
8. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
[TBL] [Abstract][Full Text] [Related]
11. Reversal of depressed oxygen consumption accompanying in vivo protamine sulphate-heparin interactions by the prostacyclin analogue, iloprost.
Wakefield TW; Wrobleski SK; Stanley JC
Eur J Vasc Surg; 1990 Feb; 4(1):25-31. PubMed ID: 1691112
[TBL] [Abstract][Full Text] [Related]
12. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
Rogers K; Milne B; Salerno TA
J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
[TBL] [Abstract][Full Text] [Related]
14. Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine.
Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Schmidt R; Tejwani S; Stanley JC
J Vasc Surg; 1995 May; 21(5):839-49; discussion 849-50. PubMed ID: 7769743
[TBL] [Abstract][Full Text] [Related]
15. Increased prostacyclin and adverse hemodynamic responses to protamine sulfate in an experimental canine model.
Wakefield TW; Wrobleski SK; Wirthlin DJ; Wang TW; Stanley JC
J Surg Res; 1991 May; 50(5):449-56. PubMed ID: 2038184
[TBL] [Abstract][Full Text] [Related]
16. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
17. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
18. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
Fontaine GV; Smith SM
Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
[TBL] [Abstract][Full Text] [Related]
19. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
20. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
Patel AA; White CM; Coleman CI
Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
